Tag Archives: Krystexxa
The Krystexxa blog brings you news and updates about pegloticase. Krystexxa is a brand of pegloticase, and this blog covers it’s development and availability. These articles support the Krystexxa (pegloticase) guidelines, where you can also find links to other forms of uricase.
Best Tophi Picture shows greatest Tophi Treatment
I think this is the best tophi picture. Because it shows successful tophi treatment. Most tophi photographs are horrible. But I think you should know the dangers of untreated gout. Despite the advances in science that mean we can now control gout, there is a tiny minority who cannot tolerate common uric acid-lowering treatment. If you do not get uric acid to safe concentration, you are doomed to the continuous growth of tophi. So, you might treat the pain, but can you control the gout? Pain relief without uric acid […]
How Is Your Krystexxa?
Krystexxa, the intravenous uric acid lowering developed as pegloticase, has been around a few months now. At least one patient, or rather his wife, has reported good initial results in the gout forum and has promised to keep us updated with progress. Any new treatment is always interesting, and people want to know more about it. The scientists get to have their say in the professional publications, but much more important, is the way treatments affect gout sufferers. Now, gout patients have a chance to tell their story. A leading […]